首页|期刊导航|中药新药与临床药理|康复新液对脂多糖诱导炎症微环境中人食管成纤维细胞损伤的作用及机制

康复新液对脂多糖诱导炎症微环境中人食管成纤维细胞损伤的作用及机制OA

Effects and Mechanism of Kangfuxin Liquid on Human Esophageal Fibroblast Injury in a LPS-Induced Inflammatory Microenvironment

中文摘要英文摘要

目的 观察康复新液(美洲大蠊提取物)对脂多糖(LPS)诱导炎症微环境中人食管成纤维细胞(HEFs)损伤的作用及机制.方法 (1)以不同浓度康复新液(0%、0.5%、1%、2%、4%、8%、16%、32%)及不同浓度LPS(0、2、4、6、8、10、20、40 μg·mL-1)对HEFs干预 24 h后,采用CCK-8 法检测HEFs细胞增殖率,筛选合适的LPS诱导浓度及康复新液干预浓度.(2)将对数生长期HEFs细胞分为对照组、LPS组、0.5%康复新液组、1%康复新液组、2%康复新液组及醋酸泼尼松龙(PDNN,50 μg·mL-1)组;采用LPS(10 μg·mL-1)刺激 1 h诱导炎症微环境.采用ELISA法检测细胞上清液中白细胞介素(IL)-1β、IL-6、肿瘤坏死因子(TNF)-α、诱导型一氧化氮合酶(iNOS)的含量;免疫荧光法检测细胞中IL-6、核因子(NF)-κB p-p65、p-Smad3、α平滑肌肌动蛋白(α-SMA)表达水平;qRT-PCR法检测细胞中IL-1β、IL-6、TNF-α、NF-κB、转化生长因子(TGF)-β1、Smad3、α-SMA mRNA表达水平;Western Blot法检测细胞中NF-κB p65、NF-κB p-p65、核因子κB抑制蛋白α(IκBα)、p-IκBα、TGF-β1、Smad3、p-Smad3、α-SMA蛋白表达水平.结果 (1)后续实验选择 0.5%、1%、2%浓度康复新液进行干预;选择 10 μg·mL-1 LPS刺激诱导HEFs炎症微环境.(2)与对照组比较,LPS组HEFs细胞上清液中的 IL-1β、IL-6、TNF-α、iNOS含量均显著上升(P<0.01);细胞IL-1β、IL-6、TNF-α、NF-κB mRNA表达均显著上调(P<0.01);细胞NF-κB p65、NF-κB p-p65、IκBα、p-IκBα蛋白表达均显著上调(P<0.01);IL-6 细胞质红色荧光信号及NF-κB p-p65 细胞核绿色荧光信号均显著增强(P<0.01);细胞TGF-β1、Smad3、α-SMA mRNA表达均显著上调(P<0.01);细胞TGF-β1、Smad3、p-Smad3、α-SMA蛋白表达均显著上调(P<0.01);p-Smad3 细胞核绿色荧光信号及α-SMA细胞质红色荧光信号均显著增强(P<0.01).与LPS组比较,0.5%、1%、2%康复新液组及PDNN组细胞上清液中的IL-6、TNF-α、iNOS含量显著降低(P<0.01);细胞NF-κB p65、NF-κB p-p65、IκBα、p-IκBα蛋白表达均显著下调(P<0.01);IL-6 细胞质红色荧光信号及NF-κB p-p65 细胞核绿色荧光信号均显著减弱(P<0.01);细胞TGF-β1、p-Smad3 蛋白表达显著下调(P<0.01);α-SMA细胞质红色荧光信号显著减弱(P<0.01).与LPS组比较,2%康复新液组及PDNN组细胞上清液中的IL-1β含量显著降低(P<0.01);细胞IL-1β、IL-6、TNF-α、NF-κB mRNA表达均显著下调(P<0.05,P<0.01);细胞 TGF-β1、Smad3、α-SMA mRNA 表达均显著下调(P<0.01);细胞Smad3、α-SMA蛋白表达显著下调(P<0.01);p-Smad3 细胞核绿色荧光信号显著减弱(P<0.01).结论 康复新液可减轻 LPS诱导炎症微环境中 HEFs细胞的损伤和肌成纤维细胞表型转化,其作用机制可能与抑制TGF-β1/Smad3 信号通路过度激活有关.该结果为康复新液治疗内镜黏膜下剥离术后的食管狭窄提供了一定的实验依据.

Objective To investigate the effects and underlying mechanism of Kangfuxin Liquid[an extract of Periplaneta americana(L.)]on human esophageal fibroblast(HEFs)injury within a lipopolysaccharide(LPS)-induced inflammatory microenvironment.Methods(1)Following intervention with varying concentrations of Kangfuxin Liquid(0%,0.5%,1%,2%,4%,8%,16%,32%)and LPS(0,2,4,6,8,10,20,40 μg·mL-1)for 24 hours,the HEFs proliferation rate was assessed via the CCK-8 assay to determine the optimal concentrations for LPS induction and Kangfuxin Liquid intervention.(2)HEFs in the logarithmic growth phase were divided into the following groups:Control,LPS,0.5%Kangfuxin Liquid,1%Kangfuxin Liquid,2%Kangfuxin Liquid,and Prednisolone Acetate(PDNN,50 μg·mL-1).An inflammatory microenvironment was induced by stimulation with LPS(10 μg·mL-1)for 1 hour.The levels of interleukin(IL)-1β,IL-6,tumor necrosis factor(TNF)-α,and inducible nitric oxide synthase(iNOS)in the cell supernatant were measured by ELISA.The expression levels of IL-6,nuclear factor(NF)-κB p-p65,p-Smad3,and α-smooth muscle actin(α-SMA)in the cells were detected by immunofluorescence.The mRNA expression levels of IL-1β,IL-6,TNF-α,NF-κB,transforming growth factor(TGF)-β1,Smad3,and α-SMA in the cells were determined using qRT-PCR.The protein expression levels of NF-κB p65,NF-κB p-p65,inhibitor of nuclear factor kappa-B alpha(IκBα),p-IκBα,TGF-β1,Smad3,p-Smad3,and α-SMA in the cells were assessed by Western Blot.Results(1)Subsequent experiments utilized Kangfuxin Liquid at concentrations of 0.5%,1%,and 2%,and an LPS concentration of 10 μ g·mL-1 to induce the inflammatory microenvironment in HEFs.(2)Compared with the control group,the LPS group exhibited significantly increased levels of IL-1β,IL-6,TNF-α,and iNOS in the HEF supernatant(P<0.01);significantly upregulated mRNA expression of IL-1β,IL-6,TNF-α,and NF-κB(P<0.01);significantly increased protein expression of NF-κB p65,NF-κB p-p65,IκBα,and p-IκBα(P<0.01);significantly enhanced cytoplasmic red fluorescence signal for IL-6 and nuclear green fluorescence signal for NF-κB p-p65(P<0.01);significantly upregulated mRNA expression of TGF-β1,Smad3,and α-SMA(P<0.01);significantly increased protein expression of TGF-β1,Smad3,p-Smad3,and α-SMA(P<0.01);and significantly intensified nuclear green fluorescence signal for p-Smad3 and cytoplasmic red fluorescence signal for α-SMA(P<0.01).Compared with the LPS group,the 0.5%,1%,and 2%Kangfuxin Liquid groups and the PDNN group showed significantly reduced levels of IL-6,TNF-α,and iNOS in the cell supernatant(P<0.01);significantly downregulated protein expression of NF-κB p65,NF-κB p-p65,IκBα,and p-IκBα(P<0.01);significantly attenuated cytoplasmic red fluorescence signal for IL-6 and nuclear green fluorescence signal for NF-κB p-p65(P<0.01);significantly decreased protein expression of TGF-β1 and p-Smad3(P<0.01);and significantly weakened cytoplasmic red fluorescence signal for α-SMA(P<0.01).Compared with the LPS group,the 2%Kangfuxin Liquid group and the PDNN group demonstrated significantly lower IL-1β content in the cell supernatant(P<0.01);significantly downregulated mRNA expression of IL-1β,IL-6,TNF-α,and NF-κB(P<0.05,P<0.01);significantly downregulated mRNA expression of TGF-β1,Smad3,and α-SMA(P<0.01);significantly decreased protein expression of Smad3 and α-SMA(P<0.01);and a significantly weakened nuclear green fluorescence signal for p-Smad3(P<0.01).Conclusion Kangfuxin Liquid can alleviate HEF injury and inhibit the phenotypic transition to myofibroblasts in an LPS-induced inflammatory microenvironment.The underlying mechanism may be associated with the suppression of the excessive activation of the TGF-β1/Smad3 signaling pathway.These findings provide experimental evidence supporting the potential use of Kangfuxin Liquid in treating esophageal strictures following endoscopic submucosal dissection.

周鑫;赵龙;王洪连;罗钰婷;李志;刘建琴

西南医科大学附属中医医院脾胃病科,四川 泸州 646000中西医结合防治消化系统疾病泸州市重点实验室,四川 泸州 646000西南医科大学附属中医医院脾胃病科,四川 泸州 646000中西医结合防治消化系统疾病泸州市重点实验室,四川 泸州 646000中西医结合防治消化系统疾病泸州市重点实验室,四川 泸州 646000西南医科大学附属中医医院中西医结合研究中心,四川 泸州 646000

医药卫生

康复新液美洲大蠊提取物食管狭窄炎症微环境人食管成纤维细胞炎症反应纤维化TGF-β1/Smad3 信号通路

Kangfuxin LiquidPeriplaneta americana extractesophageal strictureinflammatory microenvironmenthuman esophageal fibroblastsinflammatory responsefibrosisTGF-β1/Smad3 signaling pathway

《中药新药与临床药理》 2026 (1)

31-41,11

四川省科技厅重点研发项目(2020YFS0376)西南医科大学科研创新团队项目(2022-CXTD-01).

10.19378/j.issn.1003-9783.2026.01.004

评论